Annual D&A
$121.90 K
+$8400.00+7.40%
30 June 2024
Summary:
Renovaro Biosciences annual depreciation & amortization is currently $121.90 thousand, with the most recent change of +$8400.00 (+7.40%) on 30 June 2024. During the last 3 years, it has fallen by -$1600.00 (-1.30%). RENB annual D&A is now -66.72% below its all-time high of $366.30 thousand, reached on 01 June 2020.RENB Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$32.40 K
+$1300.00+4.18%
30 September 2024
Summary:
Renovaro Biosciences quarterly depreciation & amortization is currently $32.40 thousand, with the most recent change of +$1300.00 (+4.18%) on 30 September 2024. Over the past year, it has dropped by -$800.00 (-2.41%). RENB quarterly D&A is now -95.74% below its all-time high of $761.20 thousand, reached on 01 March 2018.RENB Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$127.00 K
+$5100.00+4.18%
30 September 2024
Summary:
Renovaro Biosciences TTM depreciation & amortization is currently $127.00 thousand, with the most recent change of +$5100.00 (+4.18%) on 30 September 2024. Over the past year, it has increased by +$10.30 thousand (+8.83%). RENB TTM D&A is now -83.57% below its all-time high of $772.80 thousand, reached on 01 March 2018.RENB TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RENB Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +7.4% | -2.4% | +8.8% |
| 3 y3 years | -1.3% | +1.9% | +0.9% |
| 5 y5 years | +70.0% | +11.0% | +21.1% |
RENB Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -1.4% | +7.4% | -2.4% | +18.7% | at high | +13.1% |
| 5 y | 5 years | -66.7% | +70.0% | -88.7% | +18.7% | -66.5% | +21.1% |
| alltime | all time | -66.7% | +740.7% | -95.7% | +104.3% | -83.6% | +117.4% |
Renovaro Biosciences Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $32.40 K(+4.2%) | $127.00 K(+4.2%) |
| June 2024 | $121.90 K(+7.4%) | $31.10 K(+2.6%) | $121.90 K(+2.6%) |
| Mar 2024 | - | $30.30 K(-8.7%) | $118.80 K(+1.8%) |
| Dec 2023 | - | $33.20 K(+21.6%) | $116.70 K(+3.9%) |
| Sept 2023 | - | $27.30 K(-2.5%) | $112.30 K(-1.0%) |
| June 2023 | $113.50 K(-8.2%) | - | - |
| June 2023 | - | $28.00 K(-0.7%) | $113.40 K(-0.3%) |
| Mar 2023 | - | $28.20 K(-2.1%) | $113.70 K(-3.0%) |
| Dec 2022 | - | $28.80 K(+1.4%) | $117.20 K(-2.5%) |
| Sept 2022 | - | $28.40 K(+0.4%) | $120.20 K(-2.7%) |
| June 2022 | $123.60 K(+0.1%) | $28.30 K(-10.7%) | $123.50 K(-2.5%) |
| Mar 2022 | - | $31.70 K(-0.3%) | $126.70 K(+0.7%) |
| Dec 2021 | - | $31.80 K(+0.3%) | $125.80 K(+0.8%) |
| Sept 2021 | - | $31.70 K(+0.6%) | $124.80 K(+1.0%) |
| June 2021 | $123.50 K(-66.3%) | $31.50 K(+2.3%) | $123.60 K(-67.4%) |
| Mar 2021 | - | $30.80 K(0.0%) | $379.50 K(+0.7%) |
| Dec 2020 | - | $30.80 K(+1.0%) | $376.90 K(+0.4%) |
| Sept 2020 | - | $30.50 K(-89.4%) | $375.30 K(+2.5%) |
| June 2020 | $366.30 K(+410.9%) | $287.40 K(+919.1%) | $366.30 K(+183.5%) |
| Mar 2020 | - | $28.20 K(-3.4%) | $129.20 K(+23.2%) |
| Dec 2019 | - | $29.20 K(+35.8%) | $104.90 K(+19.5%) |
| Sept 2019 | - | $21.50 K(-57.3%) | $87.80 K(+22.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2019 | $71.70 K(+287.6%) | $50.30 K(+1189.7%) | $71.70 K(-109.8%) |
| Mar 2019 | - | $3900.00(-67.8%) | -$729.30 K(-2704.6%) |
| Dec 2018 | - | $12.10 K(+124.1%) | $28.00 K(+40.7%) |
| Sept 2018 | - | $5400.00(-100.7%) | $19.90 K(+8.2%) |
| June 2018 | $18.50 K(+27.6%) | -$750.70 K(-198.6%) | $18.40 K(-97.6%) |
| Mar 2018 | - | $761.20 K(>+9900.0%) | $772.80 K(+5017.9%) |
| Dec 2017 | - | $4000.00(+2.6%) | $15.10 K(+2.7%) |
| Sept 2017 | - | $3900.00(+5.4%) | $14.70 K(+1.4%) |
| June 2017 | $14.50 K(-47.1%) | $3700.00(+5.7%) | $14.50 K(-14.2%) |
| Mar 2017 | - | $3500.00(-2.8%) | $16.90 K(+14.2%) |
| Dec 2016 | - | $3600.00(-2.7%) | $14.80 K(-45.6%) |
| Sept 2016 | - | $3700.00(-39.3%) | $27.20 K(-0.7%) |
| June 2016 | $27.40 K(+22.3%) | $6100.00(+335.7%) | $27.40 K(+28.6%) |
| Mar 2016 | - | $1400.00(-91.3%) | $21.30 K(-53.0%) |
| Dec 2015 | - | $16.00 K(+310.3%) | $45.30 K(+7.9%) |
| Sept 2015 | - | $3900.00(-84.6%) | $42.00 K(-34.1%) |
| June 2015 | $22.40 K(-50.4%) | - | - |
| Mar 2015 | - | $25.40 K(+100.0%) | $63.70 K(+41.2%) |
| Dec 2014 | $45.20 K | $12.70 K(-40.4%) | $45.10 K(+39.2%) |
| Sept 2014 | - | $21.30 K(+395.3%) | $32.40 K(+191.9%) |
| June 2014 | - | $4300.00(-36.8%) | $11.10 K(+63.2%) |
| Mar 2014 | - | $6800.00 | $6800.00 |
FAQ
- What is Renovaro Biosciences annual depreciation & amortization?
- What is the all time high annual D&A for Renovaro Biosciences?
- What is Renovaro Biosciences annual D&A year-on-year change?
- What is Renovaro Biosciences quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Renovaro Biosciences?
- What is Renovaro Biosciences quarterly D&A year-on-year change?
- What is Renovaro Biosciences TTM depreciation & amortization?
- What is the all time high TTM D&A for Renovaro Biosciences?
- What is Renovaro Biosciences TTM D&A year-on-year change?
What is Renovaro Biosciences annual depreciation & amortization?
The current annual D&A of RENB is $121.90 K
What is the all time high annual D&A for Renovaro Biosciences?
Renovaro Biosciences all-time high annual depreciation & amortization is $366.30 K
What is Renovaro Biosciences annual D&A year-on-year change?
Over the past year, RENB annual depreciation & amortization has changed by +$8400.00 (+7.40%)
What is Renovaro Biosciences quarterly depreciation & amortization?
The current quarterly D&A of RENB is $32.40 K
What is the all time high quarterly D&A for Renovaro Biosciences?
Renovaro Biosciences all-time high quarterly depreciation & amortization is $761.20 K
What is Renovaro Biosciences quarterly D&A year-on-year change?
Over the past year, RENB quarterly depreciation & amortization has changed by -$800.00 (-2.41%)
What is Renovaro Biosciences TTM depreciation & amortization?
The current TTM D&A of RENB is $127.00 K
What is the all time high TTM D&A for Renovaro Biosciences?
Renovaro Biosciences all-time high TTM depreciation & amortization is $772.80 K
What is Renovaro Biosciences TTM D&A year-on-year change?
Over the past year, RENB TTM depreciation & amortization has changed by +$10.30 K (+8.83%)